Viruses use the molecular repertoire of the host cell to replicate. Researchers want to exploit this for the treatment of influenza. The team identified a compound that inhibits the body’s own methyltransferase MTr1, thereby limiting the replication of influenza viruses. The compound proved effective in lung tissue preparations and mouse studies and showed synergistic effects with already approved influenza drugs.